KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Dividends Paid - Preferred: 2018-2021

Historic Dividends Paid - Preferred for Arbutus Biopharma (ABUS) over the last 4 years, with Dec 2021 value amounting to $574,000.

  • Arbutus Biopharma's Dividends Paid - Preferred fell 81.62% to $574,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $12.1 million, marking a year-over-year increase of 0.13%. This contributed to the annual value of $12.1 million for FY2021, which is 0.13% up from last year.
  • Arbutus Biopharma's Dividends Paid - Preferred amounted to $574,000 in Q4 2021, which was down 88.72% from $5.1 million recorded in Q3 2021.
  • In the past 5 years, Arbutus Biopharma's Dividends Paid - Preferred registered a high of $5.7 million during Q4 2019, and its lowest value of $574,000 during Q4 2021.
  • In the last 3 years, Arbutus Biopharma's Dividends Paid - Preferred had a median value of $3.0 million in 2020 and averaged $3.2 million.
  • Its Dividends Paid - Preferred has fluctuated over the past 5 years, first skyrocketed by 114.28% in 2019, then slumped by 81.62% in 2021.
  • Quarterly analysis of 4 years shows Arbutus Biopharma's Dividends Paid - Preferred stood at $2.6 million in 2018, then spiked by 114.28% to $5.7 million in 2019, then plummeted by 44.94% to $3.1 million in 2020, then tumbled by 81.62% to $574,000 in 2021.
  • Its Dividends Paid - Preferred was $574,000 in Q4 2021, compared to $5.1 million in Q3 2021 and $3.3 million in Q2 2021.